Literature DB >> 33867430

The Development of iManage-PC, an Online Symptom Monitoring and Self-management Tool for Men With Clinically Localized Prostate Cancer.

Karly M Murphy1, Christina Sauer, Dershung Yang, Niina Hass, Kristian Novakovic, Brian Helfand, Robert Nadler, Benjamin D Schalet, David Victorson.   

Abstract

BACKGROUND: Prostate cancer (PC) often impacts 4 major aspects of health-related quality of life (HRQL): urinary, sexual, and bowel dysfunction, and anxiety. Online tools may be helpful in supporting the development of self-management skills that can improve HRQL.
OBJECTIVE: The aim of this study was to develop and pilot-test an online symptom monitoring and self-management program, iManage-PC.
METHODS: A literature search, input from experts, and feedback from patients were used to develop iManage-PC. A 4-week, single-arm pilot study was conducted with 96 men with prostate cancer. We evaluated system usability, acceptance, and satisfaction and examined preliminary effects on patient-reported outcomes.
RESULTS: Rates of retention (94.8%) and adherence to symptom monitoring (95.0%-97.0%) were high. Most participants rated the tool as satisfactory and acceptable (81.2%-94.3%). Related-samples Wilcoxon signed rank tests revealed that participants reported increased self-efficacy related to their ability to manage their adverse effects (T = 1772.0, P < .001, r = 0.39), physical discomfort (T = 1259.0, P < .001, r = 0.40), and stress and worry (T = 1108.5, P = .001, r = 0.34). Global mental and physical health also improved (T = 1322.0, P = .032, r = 0.23, and T = 1409.0, P = .001, r = 0.35, respectively).
CONCLUSIONS: Future research with such tools should examine the potential role of cut-score-derived management interventions to improve engagement, symptom management self-efficacy, and HRQL. IMPLICATIONS FOR PRACTICE: Our findings are consistent with a growing body of literature that supports the feasibility and acceptability of remotely delivered interventions.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 33867430      PMCID: PMC8497651          DOI: 10.1097/NCC.0000000000000948

Source DB:  PubMed          Journal:  Cancer Nurs        ISSN: 0162-220X            Impact factor:   2.592


  28 in total

1.  G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences.

Authors:  Franz Faul; Edgar Erdfelder; Albert-Georg Lang; Axel Buchner
Journal:  Behav Res Methods       Date:  2007-05

2.  Feasibility of an interactive ICT-platform for early assessment and management of patient-reported symptoms during radiotherapy for prostate cancer.

Authors:  Kay Sundberg; Ann Langius Eklöf; Karin Blomberg; Ann-Kristin Isaksson; Yvonne Wengström
Journal:  Eur J Oncol Nurs       Date:  2015-03-23       Impact factor: 2.398

3.  Reliability and construct validity of PROMIS® measures for patients with heart failure who undergo heart transplant.

Authors:  Kathryn E Flynn; Mary Amanda Dew; Li Lin; Maria Fawzy; Felicia L Graham; Elizabeth A Hahn; Ron D Hays; Robert L Kormos; Honghu Liu; Mary McNulty; Kevin P Weinfurt
Journal:  Qual Life Res       Date:  2015-06-03       Impact factor: 4.147

4.  Enhancing self-efficacy for optimized patient outcomes through the theory of symptom self-management.

Authors:  Amy J Hoffman
Journal:  Cancer Nurs       Date:  2013 Jan-Feb       Impact factor: 2.592

5.  Effect of a self-management program on patients with chronic disease.

Authors:  K R Lorig; D S Sobel; P L Ritter; D Laurent; M Hobbs
Journal:  Eff Clin Pract       Date:  2001 Nov-Dec

6.  Presence of symptom distress and prostate cancer-related anxiety in patients at the beginning of cancer rehabilitation.

Authors:  Anja Mehnert; Claudia Lehmann; Thomas Schulte; Uwe Koch
Journal:  Onkologie       Date:  2007-10-16

Review 7.  Grounded theory: an exploration of process and procedure.

Authors:  Diane Walker; Florence Myrick
Journal:  Qual Health Res       Date:  2006-04

8.  Factors Affecting Quality of Life at Different Intervals After Treatment of Localized Prostate Cancer: Unique Influence of Treatment Decision Making Satisfaction, Personality and Sexual Functioning.

Authors:  David E Victorson; Stephanie Schuette; Benjamin D Schalet; Shilajit D Kundu; Brian T Helfand; Kristian Novakovic; Nathaniel Sufrin; Michael McGuire; Charles Brendler
Journal:  J Urol       Date:  2016-05-31       Impact factor: 7.450

9.  Long-term health-related quality of life of prostate cancer survivors varies by primary treatment. Results from the PiCTure (Prostate Cancer Treatment, your experience) study.

Authors:  Frances Josephine Drummond; Heather Kinnear; Eamonn O'Leary; Anna Gavin; Linda Sharp
Journal:  J Cancer Surviv       Date:  2015-01-07       Impact factor: 4.442

10.  Measuring Engagement in eHealth and mHealth Behavior Change Interventions: Viewpoint of Methodologies.

Authors:  Camille E Short; Ann DeSmet; Catherine Woods; Susan L Williams; Carol Maher; Anouk Middelweerd; Andre Matthias Müller; Petra A Wark; Corneel Vandelanotte; Louise Poppe; Melanie D Hingle; Rik Crutzen
Journal:  J Med Internet Res       Date:  2018-11-16       Impact factor: 5.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.